Date: March 11th 2009


 

Record Number of Investors at BioTrinity 2009

If you are seeking financing in the next one to two years, or if you have a colleague or client seeking financing - it may well be worth making sure that BioTrinity 2009 is on the radar given our growing roll call of senior international investors attending on April 2nd and 3rd:

 Abingworth Management (Principal)
 Advent Venture Partners (Principal)
 Albion Ventures LLP (Director)
 Andy Richards (Serial Entrepreneur)
 Atlas Venture (Partner and Analyst)
 Avlar BioVentures (CEO)
 BSI SA (Chief Investment Officer, VP, Private Equity, Italy)
 Canaccord Adams (MD)
 Edmond de Rothschild Investment Partners (Partner, France)
 Entrepreneurs Fund LLP (Associate)
 Esperante Ventures (MD, Netherlands)
 ETV Capital (Deal Executive)
 Excalibur Group (Investment Director, formerly Merlin Biosciences)
 Forbion Capital Partners (Principal)
 Genzyme Ventures (Associate)
 H2O Venture Partners (Co-founder and CEO)
 IP Group plc (Client Services Manager)
 Ipso Ventures (Executive Director)
 IQ Capital (Managing Partner, Co-founder)
 Mercia Technology Seed Fund (Principal)
 MP Healthcare Venture Management (VP, USA)
 MVM Life Science Partners (Finance Director)
 Nomura Code Securities (Director, Corporate Finance)
 Novo A/S (Senior Partner, Denmark)
 Orion Healthcare Equity Partners (Partner)
 Oxford Capital Partners (Investment Director and Investment Manager)
 Oxford Technology Management (Founder, MD and Seed Capital Team)
 Piper Jaffray (Head of European Equity Research)
 Rainbow Seed Fund (Investment Manager)
 Seraphim Capital (General Partner)
 Seroba Kernel (Partner, Ireland)
 SPARK Ventures (Investment Director)
 SR One (General Partner, USA)
 Takeda Research Investment, Inc (President & CEO, USA)
 The Wellcome Trust (Head of Business Development)

See who else is attending...

These investors cover the breadth of life sciences investment, from biotech, to medtech and diagnostics, at all stages, from seed to late-stage. BioTrinity 2009 will also deal with the new reality of biotech and medtech finance in our Investor Panel Discussion, analysing trends and dealing with a few current myths. This panel features Dr. Regina Hodits, Partner at Atlas Venture, Martin Edwards, Senior Partner at Novo A/S, Graeme R Martin Ph.D., President & CEO of TRI, Allison Robbins, Senior Associate at Genzyme Ventures, Sam Fazeli PhD, Head of European Equity Research at Piper Jaffray, and David Mott, Investment Director Oxford Capital Partners.

Given the tough economic climate of 2009, we have strived to provide the largest number of VCs and other investors possible at BioTrinity 2009, tripling the number of investors attending, a transformation we intend to repeat at BioTrinity 2010.   

Among the 500-600 expected, there will be delegates from 15 countries will be present, and 35 corporate presentations will be heard from companies selected from Oxford, London, Cambridge as well as Bristol, Southampton, Kent, Nottingham, Manchester and Newcastle, making BioTrinity a veritable UK Biotechnology Showcase.  The latest addition to this is Heptares Therapeutics, which just completed a 21m funding round.

If you're seeking solutions to tough financing conundrums, choose BioTrinity 2009

...........................................................................................

What other people think:

"My first time at a UK partnering conference was BioTrinity 2008, and I did a deal with an NZ pharma as a direct result". Allen Hakimi, Managing Director at Technomark Life Sciences

"As a direct result of our focused partnering meetings we introduced proteros to potential clients at BioTrinity 2008 which we are pleased to report resulted in several new opportunities and one of which has developed into a substantial business relationship". Gordon J Woodrow, VP at Proteros biostructures GmbH

"...I would like to congratulate you on an excellent meeting.."
Tim Haines, Partner, Abingworth Management

"...Congratulations on such a good event. I had a very productive day with lots of organized and impromptu meetings - a very worthwhile event for me." Dr Charles Potter, CEO, Glide Pharma

Read more testimonials...

Register online now! www.biotrinity.com

Register online now at www.biotrinity.com

............................................................................................

Thanks to our Sponsors:

............................................................................................

BioTrinity is organised by OBN - Rapidly becoming the UK's leading biotech network

OBN 

2006-2009 OBN

<< Previous: BioTrinity - Keep me informed Record Registrations - Only Four Weeks Left to Register (Partnering is Live)

| Archive Index |

Next: BioTrinity - Keep me informed Partnering surges at BioTrinity 2009 - just 10 working days left to register >>

(archive rss , atom )

this list's archives:


This list is for those who wish to stay informed about developments in the BioTrinity conference programme, to find out when there are new announcements, when the online partnering service and company profiles are online, presentation or sponsorship opportunities, and most importantly when registration opens!

BioTrinity - BioPartnering Meeting and Company Showcase
April 2nd-3rd 2009 - Oxford

Subscribe/Unsubscribe on BioTrinity - Keep me informed

* Required



Powered by Dada Mail 3.0.0 beta 3 - 05/19/08
Copyright © 1999-2008, Simoni Creative.

Go back to Visit the BioTrinity website